Accelerate Diagnostics, Inc. has announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology – ASM Microbe in New Orleans, LA.


The data comes from external studies that evaluated the potential clinical and workflow benefits of the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit compared to current methods. The studies also include new early stage research on potential whole blood applications.


ASM Microbe attendees can learn more about the potential impacts of faster antibiotic susceptibility results direct from positive blood cultures on patient treatment and antimicrobial stewardship at four Industry and Science presentations, two live and unscripted Q&A sessions with early clinical adopters, and ten poster presentations.


All presentations will be held at the ASM Microbe Annual Meeting June 2nd and 3rd in the Ernst N. Morial Convention Center in New Orleans, LA.


For schedule information, speaker details, and a list of poster presentations, visit acceleratediagnostics.com/asm2017.



Source & Image Credit: Accelerate Diagnostics, Inc.


«« Antibiotics for Sepsis - Does Each Hour Really Count?


Urine Output Monitoring and Early AKI Detection »»



Latest Articles

Accelerate Diagnostics,ASM Microbe 2017,American Society for Microbiology ,Accelerate Pheno™ system,Accelerate PhenoTest™ BC kit Accelerate Diagnostics, Inc. today announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology – ASM Microbe in New Orleans, LA.